Avid Bioservices Inc (CDMO)

[biopharm]

Omics + big data + biomarker-guided drug development. It’s a new reality, bringing unprecedented abilities to interrogate and translate biological information—and unprecedented opportunities for life sciences companies to achieve their goals faster and more cost-effectively. This fundamental shift requires a new approach to drug development.

Only if the new BODs were ones that resisted and went full speed ahead to maximize shareholder value and aligned 100% with their Fiduciary Duties....

Looks like current shareholders will get watered down profits to come.....although, I admit....profits are coming and breakeven soon it seems

PS Targeting related client orders will make up ...I bet....OVER 50% of the earnings to come

Will the new BODs admit that most of the profits realized will be due.....to PS Targeting clients/orders, where Stafford Ronin Hedge group NEVER publicly stated the potential of PS Targeting...

Nope